PETS (PetMed Express) Piotroski F-Score: 2 (As of Jun. 26, 2026) — 60% Below Median


PETS PetMed Express Inc PETS
56 GF Score
Price $1.76
GF Value $2.87
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PetMed Express Piotroski F-Score?

PetMed Express PETS -0.56% 56 Piotroski F-Score is 2 as of Jun. 26, 2026, which is 60% below its 10-year median of 5.00. GuruFocus rates PETS with a GF Score™ of 56/100 and a GF Value™ of $2.87 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 652 Healthcare Providers & Services companies, PetMed Express ranks worse than 92.94% on this metric.

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PetMed Express has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for PetMed Express's Piotroski F-Score or its related term are showing as below:

PETS' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 7
Current: 2

During the past 13 years, the highest Piotroski F-Score of PetMed Express was 7. The lowest was 2. And the median was 5.

PetMed Express  (NAS:PETS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


PetMed Express Piotroski F-Score Related Terms


PetMed Express Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for PetMed Express's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PetMed Express Piotroski F-Score Chart

PetMed Express Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 5.00 3.00 4.00 2.00

PetMed Express Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 3.00 2.00 2.00

PETS vs BHIC, SHFH, SCNX: Piotroski F-Score Comparison

For the Pharmaceutical Retailers subindustry, PetMed Express's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PetMed Express Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where PetMed Express's Piotroski F-Score falls into.


PETS
56GF Score
PetMed Express Inc PETS
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -34.152 + -8.52 + -10.553 + -4.061 = $-57.3 Mil.
Cash Flow from Operations was -12.271 + -2.174 + -9.205 + -4.744 = $-28.4 Mil.
Revenue was 51.18 + 44.364 + 40.66 + 42.817 = $179.0 Mil.
Gross Profit was 14.403 + 12.415 + 9.456 + 13.942 = $50.2 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(148.7 + 109.839 + 100.301 + 87.965 + 81.191) / 5 = $105.5992 Mil.
Total Assets at the begining of this year (Mar25) was $148.7 Mil.
Long-Term Debt & Capital Lease Obligation was $0.0 Mil.
Total Current Assets was $43.6 Mil.
Total Current Liabilities was $52.0 Mil.
Net Income was 3.754 + 2.326 + -0.707 + -11.644 = $-6.3 Mil.

Revenue was 66.207 + 58.044 + 51.961 + 50.76 = $227.0 Mil.
Gross Profit was 19.037 + 18.773 + 16.131 + 15.196 = $69.1 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(169.884 + 152.714 + 146.034 + 144.795 + 148.7) / 5 = $152.4254 Mil.
Total Assets at the begining of last year (Mar24) was $169.9 Mil.
Long-Term Debt & Capital Lease Obligation was $0.5 Mil.
Total Current Assets was $78.9 Mil.
Total Current Liabilities was $62.8 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PetMed Express's current Net Income (TTM) was -57.3. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PetMed Express's current Cash Flow from Operations (TTM) was -28.4. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-57.286/148.7
=-0.38524546

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-6.271/169.884
=-0.03691342

PetMed Express's return on assets of this year was -0.38524546. PetMed Express's return on assets of last year was -0.03691342. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

PetMed Express's current Net Income (TTM) was -57.3. PetMed Express's current Cash Flow from Operations (TTM) was -28.4. ==> -28.4 > -57.3 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=0.042/105.5992
=0.00039773

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0.535/152.4254
=0.00350991

PetMed Express's gearing of this year was 0.00039773. PetMed Express's gearing of last year was 0.00350991. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=43.564/52.034
=0.83722182

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=78.871/62.768
=1.25654792

PetMed Express's current ratio of this year was 0.83722182. PetMed Express's current ratio of last year was 1.25654792. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

PetMed Express's number of shares in issue this year was 21.031. PetMed Express's number of shares in issue last year was 20.638. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=50.216/179.021
=0.2805034

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=69.137/226.972
=0.30460585

PetMed Express's gross margin of this year was 0.2805034. PetMed Express's gross margin of last year was 0.30460585. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=179.021/148.7
=1.2039072

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=226.972/169.884
=1.33604106

PetMed Express's asset turnover of this year was 1.2039072. PetMed Express's asset turnover of last year was 1.33604106. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PetMed Express has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 2 mean?
PetMed Express (PETS) has a Piotroski F-Score of 2 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PetMed Express and its competitors. This is 60% below median its historical median of 5.00. Over the past decade, PetMed Express' Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, PetMed Express ranks #606 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 92.9%.
Is PetMed Express' Piotroski F-Score too high?
PetMed Express' current Piotroski F-Score of 2 is 60% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. PetMed Express' value of 2 is 60% below this industry median. Based on the distribution chart, PetMed Express ranks #606 out of 652 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' Piotroski F-Score compare to BHIC and SHFH?
According to the Healthcare Providers & Services industry distribution chart, PetMed Express ranks #606 out of 652 companies for Piotroski F-Score. This places PetMed Express in the lower half of its industry. The industry median Piotroski F-Score is 5.00. PetMed Express' value of 2 is 60% below this benchmark. Historically, PetMed Express' own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, PetMed Express has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PetMed Express's current Piotroski F-Score of 2 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PetMed Express and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetMed Express's current Piotroski F-Score is 2, which is 60% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.87, compared to a current price of $1.76 — trading 38.7% below its estimated fair value. The current Piotroski F-Score is 2, which is 60% below median its 10-year median of 5.00 and 60% below the Healthcare Providers & Services industry median of 5.00. PetMed Express' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For PetMed Express (PETS), the current Piotroski F-Score is 2 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PetMed Express (PETS) Overvalued in 2026?

Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued. The current stock price of $1.76 is trading 38.7% below its estimated GF Value™ of $2.87. GuruFocus considers PetMed Express to be Possible Value Trap.

Key valuation signals for PETS:

  • Piotroski F-Score: 2 (60% below median its 10-year median of 5.00)
  • GF Value™: $2.87 vs. price of $1.76 (38.7% below fair value)
  • GF Score™: 56/100 with 4 warning signs
  • Industry Position: 60% below the Healthcare Providers & Services median (#606 of 652)

No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PetMed Express Business Description

Address 420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score

Get the complete analysis for PETS

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.76
Price
$2.87
GF Value